Antiphospholipid antibody syndrome (APS) is an autoimmune disease caused by the persistence of antiphospholipid antibodies. Moreover, there is a significantly increased risk of pregnancy complications in women with APS. The treatment is antithrombotic therapy. However, heparin-induced thrombocytopenia (HIT) is known as a severe complication of heparin utilization. HIT is an autoimmune disease caused by anti-heparin antibodies. Nevertheless, patients with APS frequently receive heparin as treatment for thrombotic events. The authors report a case of a Japanese woman with Sjogren's syndrome (SjS) and deep vein thrombosis who became pregnant following assisted reproduction technology. However, she suffered an intrauterine fetal death associated with HIT.
CITATION STYLE
Sanai, H., Miyamoto, T., Minase, G., Sanai, Y., Ueda, H., & Sengoku, K. (2017). A case of a pregnant patient with antiphospholipid antibody syndrome, deep vein thrombosis, and heparin-induced thrombocytopenia who suffered an intrauterine fetal death. Clinical and Experimental Obstetrics and Gynecology, 44(6), 939–940. https://doi.org/10.12891/ceog3565.2017
Mendeley helps you to discover research relevant for your work.